News

Innovative Marketing Partnerships for Treatment.com AI Success

Innovative Marketing Partnerships for Treatment.com AI Success

Strategic Marketing Engagements for Enhanced Visibility

Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) is excited to share its new collaboration with marketing partners. The company has recently engaged with 45 Degrees, Inc. and Investment Publishing LLC to elevate its marketing and investor relations strategies.

Collaboration with 45 Degrees, Inc.

45 Degrees, based in Wyoming, will provide a comprehensive range of advertising services for Treatment.com AI. This partnership is set to commence immediately and has been structured as a six-month Marketing Engagement. The total fee of USD $180,000 will be divided into two equal payments: the initial payment upon signing and a second payment ten weeks post-campaign launch. In addition, there's an option to extend the engagement with a monthly fee of USD $25,000 by mutual consent.

As part of this arrangement, Treatment has opted to issue 400,000 stock options to the principal of 45 Degrees. These options have an exercise price of $0.45 per share and will vest immediately, allowing flexibility and incentivizing performance over a three-year period.

Investment Publishing Engagement

Further enhancing its approach to investor relations, Treatment.com AI has engaged Investment Publishing with a focus on elevating the company's presence within the investment community. This engagement will last for a year and aims to boost investor awareness through public relations, engaging educational content, and proactive outreach across multiple digital platforms including social media.

Compensation for Investment Publishing includes an issuance of 400,000 stock options, similar to the arrangement with 45 Degrees, further solidifying the commitment towards partnership success while ensuring stakeholders benefit from these alliances.

Additional Stock Options Granted

In addition to the above engagements, Treatment has announced the granting of an aggregate of 400,000 options to external consultants under the company’s stock option plan. These options will also be exercisable at a price of $0.45 per share for a duration of three years. Such measures not only align with the company's growth strategy but also enhance its ability to attract quality talent.

About Treatment.com AI Inc.

Treatment.com AI aimed at revolutionizing healthcare through artificial intelligence and established clinical practices. With insights from healthcare professionals worldwide, the company has developed the Global Library of Medicine (GLM), a comprehensive AI engine that assists healthcare providers by streamlining resources and reducing administrative burdens. By leveraging more than 10,000 expert medical reviews, the GLM delivers accurate clinical information and supports healthcare experts in making informed decisions.

Benefits of the Global Library of Medicine

The GLM platform not only eases workloads for healthcare professionals but also promotes better patient interactions. It effectively bridges gaps for underrepresented communities in healthcare, thereby enhancing overall accessibility and equity.

Contact for Further Information

For any further inquiries, please contact Dr. Essam Hamza, the CEO of Treatment.com AI, via email at ehamza@treatment.com. The company is also available for media contacts at media@treatment.com.

Call the company at +1 (612) 788-8900 or toll-free in the USA and Canada at +1 (888) 788-8955.

Frequently Asked Questions

What is the primary goal of Treatment.com AI's new partnerships?

The partnerships aim to enhance marketing strategies and investor relations to drive growth and visibility.

Who are the marketing service providers engaged by Treatment.com AI?

Treatment.com AI has engaged 45 Degrees, Inc. for advertising services and Investment Publishing LLC for investor relations initiatives.

How long is the term of engagement with 45 Degrees?

The engagement with 45 Degrees is for a six-month term with options for extension on a month-to-month basis.

What benefits does the Global Library of Medicine provide?

The GLM assists healthcare professionals by alleviating administrative burdens, improving patient interactions, and promoting equity in healthcare access.

What is the exercise price for the stock options granted?

The exercise price for the stock options granted to both 45 Degrees and Investment Publishing is $0.45 per common share.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gildan Class Action: What Investors Should Know

Updated Category News Views 43

Playing Hardball: Gildan Faces Serious Claims Gildan Activewear Inc. (NYSE:GIL) isn't just dealing with wardrobe malfunctions; it's knee-deep in a class action lawsuit that's got investors on edge. The allegations? Accusations of deceptive practices like channel stuffing, which supposedly jazzed up their financials by moving unsold products through distribution channels...

Continue Reading
Blue Friday Sales: A Princess Cruises' Steal

Updated Category News Views 194

Setting Sail on Savings: Princess Cruises' Offerings When folks start talking about Black Friday, you probably think of TVs or gadgets, but Princess Cruises is flipping that idea with their 'Blue Friday' sale, running from November 6 through December 7, 2026. Now, cruises aren't your traditional doorbuster, but a vacation might just be the kind of experience worth...

Continue Reading
Andersen's Window Revamp: Addressing Demand Surge

Updated Category News Views 96

Portfolio Boost: Adapting to Market Needs If you're sniffing around the windows business, there's a fresh breeze of innovation blowing from Andersen. They're not just sitting around drumming their fingers—they're rolling up their sleeves and fine-tuning their offerings. With half of homeowners swinging a hammer on renovations last year, the company sees an opportunity...

Continue Reading
AZZ Inc.'s 2026 Sustainability Report: A Closer Look

Updated Category News Views 160

Diving into AZZ's Sustainability Commitment AZZ Inc., known in the trading circles as NYSE:AZZ, has just dropped its 2026 Sustainability Report and it’s quite the document to chew on. This ain't your typical corporate fluff. Tom Ferguson, the man steering the AZZ ship, laid it down plain and simple. This report isn’t just about ticking boxes for ESG; it’s reflecting...

Continue Reading
Lagoon Furniture Redefines Hospitality At BDNY 2026

Updated Category News Views 116

Revolutionizing Hospitality Design: A New Wave Some companies play it safe, sticking to tried-and-true approaches, but then there's Lagoon Furniture USA who's taking the bull by the horns with their fresh take on hospitality design ahead of BDNY 2026. Forget about following a set recipe; they're all about crafting unique identities for spaces! From Chairs to Sculptural...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 131

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 190

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Koppers Navigates Q3: Margins Squeeze Amid Growth

Updated Category News Views 123

Investing in Koppers: A Mixed Bag in Q3 Well, it appears Koppers (NYSE: KOP) is doing a bit of a dance this quarter—some smooth steps, but a few stumbles in the rhythm when it comes to margins. The hardwood numbers tell an interesting tale, so let's break it down. Sales Edge Up, But Margins Suffer Koppers clocked in net sales of $499.1 million for the third quarter of...

Continue Reading
F&G Boosts Dividend for Investors in Strong Signal

Updated Category News Views 251

Ring the Bell: Dividend Hike from F&G F&G Annuities & Life (NYSE: FG) just raised its dividend, and every investor worth their salt knows that means something. A 4% bump up to $0.26 per common share might not sound like a fanfare, but in the land of finance, it's an indication that this company thinks it's riding a positive wave. It’s like getting a little bonus in your...

Continue Reading
Reliving the Legacy of Friendship at Friends & Co

Updated Category News Views 152

Reconnecting With History In an era dominated by fleeting digital interactions, the heartening effort by Friends & Co stands out. This nonprofit is digging back into its roots and asking folks to share tales of the deep bonds formed over the past fifty years under its former guise, Little Brothers – Friends of the Elderly Twin Cities. The mission? To celebrate...

Continue Reading

Top 5 Most Recently Viewed Articles

Join Our Insightful Investor Webinar on Upcoming Bond Issues

Updated Category News Views 152

Exploring Opportunities in Renewable Energy Investments Atsinaujinan?ios Energetikos Investicijos is excited to extend an invitation for investors to attend an informative webinar focused on an upcoming bond issue. This event promises to provide valuable insights and information for potential investors interested in renewable energy ventures. Webinar Details You Can't...

Continue Reading
4DMedical Secures Major Funding to Expand Lung Imaging Solutions

Updated Category News Views 175

4DMedical Secures Major Funding for U.S. Expansion 4DMedical, a pioneer in software-based respiratory imaging technology, has achieved a significant milestone by securing over US$100 million in funding. This capital influx aims to exponentially accelerate the adoption of their innovative CT:VQ™ imaging product in the United States. Importance of CT:VQ™ Imaging...

Continue Reading
The Future of Anti-Counterfeit Packaging: Market Analysis

Updated Category News Views 139

Understanding the Anti-Counterfeit Packaging Market In recent years, the anti-counterfeit packaging market has been witnessing significant growth. Analysts project that it will reach an impressive USD 571.77 billion by the year 2034. Notably, the market saw a remarkable expansion from USD 148.73 billion in 2023 to around USD 165.74 billion in 2024. This trajectory implies...

Continue Reading
Ontex's Strategic Shift: Selling Brazilian Operation to Softys

Updated Category News Views 106

Ontex Group NV grabbed attention back in 2024 with its decision to sell off its Brazilian operations to Softys S. A. for a hefty BRL 671 million—around €110 million. This move wasn’t just some casual shuffle; it was a strategic play aimed at reshaping Ontex's portfolio. Why Ontex Sold: Strategic Shift or Desperation? Gustavo Calvo Paz, the CEO of Ontex, was vocal...

Continue Reading
Tesla's Cybercab Tests Bring Excitement Amid Model Y Updates

Updated Category News Views 300

Tesla Inc. Launches New Cybercab Testing Phase Tesla Inc. (NASDAQ: TSLA) is making waves in the electric vehicle sector as testing for its latest innovation, the Cybercab, unfolds at Gigafactory Texas and Fremont, California. This comes at an exciting juncture where the company has just unveiled affordable trims for its popular Model Y and Model 3. Cybercab Sighted at...

Continue Reading